HKSE - Delayed Quote HKD

Suzhou Basecare Medical Corporation Limited (2170.HK)

2.900
0.000
(0.00%)
As of 1:04:31 PM GMT+8. Market Open.
Loading Chart for 2170.HK
  • Previous Close 2.900
  • Open 2.900
  • Bid 2.850 x --
  • Ask 2.890 x --
  • Day's Range 2.900 - 2.900
  • 52 Week Range 1.290 - 4.450
  • Volume 500
  • Avg. Volume 161,374
  • Market Cap (intraday) 793.225M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -0.970
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.93

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People's Republic of China and Australia. The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also offers liquid nitrogen storage dewar, Cryopreservation system, and sperm quality analyzer; universal kits for sequencing effects; sample preservation solution; and nucleic acid purification and DNA extraction kits. The company also engages in the research, development, manufacture, and sale of testing kits, testing devices, and instruments. In addition, it provides marketing services; and engages in the research and development of software for testing devices and instruments. The company serves hospitals and reproductive clinics. Suzhou Basecare Medical Corporation Limited was incorporated in 2010 and is headquartered in Suzhou, China.

www.basecare.cn

497

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2170.HK

View More

Performance Overview: 2170.HK

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2170.HK
5.84%
HANG SENG INDEX (^HSI)
16.95%

1-Year Return

2170.HK
20.83%
HANG SENG INDEX (^HSI)
23.00%

3-Year Return

2170.HK
18.31%
HANG SENG INDEX (^HSI)
17.90%

5-Year Return

2170.HK
90.33%
HANG SENG INDEX (^HSI)
1.41%

Compare To: 2170.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2170.HK

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    793.23M

  • Enterprise Value

    407.99M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.45

  • Price/Book (mrq)

    0.64

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -79.25%

  • Return on Assets (ttm)

    -9.38%

  • Return on Equity (ttm)

    -18.68%

  • Revenue (ttm)

    299.11M

  • Net Income Avi to Common (ttm)

    -237.03M

  • Diluted EPS (ttm)

    -0.970

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    687.16M

  • Total Debt/Equity (mrq)

    28.76%

  • Levered Free Cash Flow (ttm)

    -267.63M

Research Analysis: 2170.HK

View More

Company Insights: 2170.HK

Research Reports: 2170.HK

View More

People Also Watch